Neuromed: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Neuromed
Largest movements
- Receivables within one year +€67,621
up €67,621 (+102%), from €66,046 to €133,667
of which Other amounts receivable: +€70,796
- Cash -€10,742
down €10,742 (-23.3%), from €46,037 to €35,295
mainly Contributions, distributions and other (-€91,400) and Receivables within one year (-€67,621)
- Tangible fixed assets -€9,867
down €9,867 (-33.0%), from €29,877 to €20,010
- Current investments +€7,000
new in 2025: €7,000
- Tax, wage and social debts +€39,678
up €39,678 (+219%), from €18,113 to €57,791
- Reserves +€26,482
up €26,482 (+28.9%), from €91,498 to €117,981
- Debts after one year -€11,484
down €11,484 (-62.1%), from €18,489 to €7,005
- Gross operating margin +€75,606
up €75,606 (+83.2%), from €90,903 to €166,510
- Taxes +€21,566
up €21,566 (+119%), from €18,113 to €39,678
- Financial income +€3,092
up €3,092 (+130%), from €2,375 to €5,467
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €141,960 | €196,812 | +€54,852 | +38.6% |
| Fixed assets | 21/28 | €29,877 | €20,850 | -€9,027 | -30.2% |
| Tangible fixed assets | 22/27 | €29,877 | €20,010 | -€9,867 | -33.0% |
| Furniture and vehicles | 24 | €29,877 | €20,010 | -€9,867 | -33.0% |
| Financial fixed assets | 28 | - | €840 | +€840 | |
| Current assets | 29/58 | €112,083 | €175,962 | +€63,879 | +57.0% |
| Amounts receivable within one year | 40/41 | €66,046 | €133,667 | +€67,621 | +102% |
| Trade receivables | 40 | €4,378 | €1,204 | -€3,174 | -72.5% |
| Other amounts receivable | 41 | €61,668 | €132,463 | +€70,796 | +115% |
| Current investments | 50/53 | - | €7,000 | +€7,000 | |
| Cash at bank and in hand | 54/58 | €46,037 | €35,295 | -€10,742 | -23.3% |
| Deferred charges and accrued income | 490/1 | €0 | - | = | |
| Total equity and liabilities | 10/49 | €141,960 | €196,812 | +€54,852 | +38.6% |
| Equity | 10/15 | €93,998 | €120,481 | +€26,482 | +28.2% |
| Contributions | 10/11 | €2,500 | €2,500 | = | 0.0% |
| Reserves | 13 | €91,498 | €117,981 | +€26,482 | +28.9% |
| Distributable reserves | 133 | €91,498 | €117,981 | +€26,482 | +28.9% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Amounts payable | 17/49 | €47,962 | €76,331 | +€28,369 | +59.2% |
| Amounts payable after more than one year | 17 | €18,489 | €7,005 | -€11,484 | -62.1% |
| Financial debts | 170/4 | €18,489 | €7,005 | -€11,484 | -62.1% |
| Amounts payable within one year | 42/48 | €29,473 | €69,326 | +€39,854 | +135% |
| Current portion of amounts payable after more than one year | 42 | €10,854 | €11,484 | +€630 | +5.8% |
| Trade debts | 44 | €506 | €51 | -€455 | -89.9% |
| Suppliers | 440/4 | €506 | €51 | -€455 | -89.9% |
| Taxes, remuneration and social security | 45 | €18,113 | €57,791 | +€39,678 | +219% |
| Taxes | 450/3 | €18,113 | €57,791 | +€39,678 | +219% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €11,433 | €12,380 | +€948 | +8.3% |
| Other operating charges | 640/8 | €775 | €547 | -€228 | -29.4% |
| Gross operating margin | 9900 | €90,903 | €166,510 | +€75,606 | +83.2% |
| Operating profit (loss) | 9901 | €78,696 | €153,583 | +€74,887 | +95.2% |
| Financial income | 75/76B | €2,375 | €5,467 | +€3,092 | +130% |
| Recurring financial income | 75 | €2,375 | €5,467 | +€3,092 | +130% |
| Financial charges | 65/66B | €2,062 | €1,489 | -€573 | -27.8% |
| Recurring financial charges | 65 | €2,062 | €1,489 | -€573 | -27.8% |
| Profit (loss) for the period before taxes | 9903 | €79,008 | €157,561 | +€78,552 | +99.4% |
| Income taxes | 67/77 | €18,113 | €39,678 | +€21,566 | +119% |
| Profit (loss) for the period | 9904 | €60,896 | €117,882 | +€56,986 | +93.6% |
| Profit (loss) for the period to be appropriated | 9905 | €60,896 | €117,882 | +€56,986 | +93.6% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 23 October 2026 via checked.be.